
Emtri S 250mg/125mg Injection
Marketer
Captab Biotec
Salt Composition
Ceftriaxone (250mg) + Sulbactam (125mg)
Overview Emtri S 250mg/125mg Injection
Combiflox 250mg/125mg Injection, a dual-action medication, combats diverse bacterial infections by inhibiting microbial proliferation and halting infection spread. Administration must be strictly under a doctor's guidance; missed doses should be avoided, and the prescribed treatment cycle completed regardless of symptom improvement. Premature cessation may compromise its effectiveness. Potential side effects include nausea, vomiting, diarrhea, and dyspepsia; worsening symptoms require immediate medical attention. Seek immediate help for allergic reactions (rash, itching, swelling, respiratory distress). Inform your physician about all current medications, especially if pregnant or breastfeeding, before initiating treatment. Alcohol consumption should be avoided due to potential increased drowsiness. While generally non-impairing to driving ability, avoid driving if experiencing drowsiness or dizziness. Adequate rest, a balanced diet, and sufficient hydration promote faster recovery. Your doctor may order lab tests to monitor the medication's impact.
Uses of Emtri S 250mg/125mg Injection
Infections caused by bacteria
Major Benefits of Emtri S 250mg/125mg Injection:
This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.
Common Side effects of Emtri S 250mg/125mg Injection:
- Increased white blood cell count (eosinophils)
- Decreased white blood cell count (lymphocytes)
- Low blood platelets
- Rash
- Diarrhea
- Increased liver enzymes
- Injection site reactions (pain, swelling, redness)
How to use Emtri S 250mg/125mg Injection:
This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.
How Emtri S 250mg/125mg Injection works:
Ceftriaxone and Sulbactam, combined as Emtri S 250mg/125mg Injection, offer a dual-action approach to bacterial infections. Ceftriaxone, a cephalosporin antibiotic, disrupts bacterial cell wall synthesis, hindering their ability to thrive. Sulbactam, a beta-lactamase inhibitor, counters bacterial resistance mechanisms, thereby bolstering Ceftriaxone's effectiveness.
SAFETY ADVICE
AlcoholSAFE
There are no known adverse reactions from concurrent use of Emtri S 250mg/125mg Injection and alcohol.
PregnancySAFE IF PRESCRIBED
The injectable medication Emtri S 250mg/125mg is typically deemed safe for use during gestation. Preclinical trials in animals revealed minimal or no negative impacts on fetal development; nevertheless, data from human trials are scarce.
Breast feedingCAUTION
Administering Emtri S 250mg/125mg Injection to breastfeeding mothers requires careful consideration. Lactation should be temporarily discontinued throughout the mother's treatment course and until the medication is fully cleared from her system.
DrivingUNSAFE
The administration of Emtri S 250mg/125mg Injection might reduce vigilance, impair visual acuity, and induce drowsiness or vertigo. Driving should be avoided if such effects manifest.
KidneyCONSULT YOUR DOCTOR
Data regarding the administration of Emtri S 250mg/125mg Injection to individuals with renal impairment is scarce. Seek medical advice from your physician.
LiverCAUTION
The Emtri S 250mg/125mg Injection requires careful administration for individuals suffering from severe hepatic impairment; dosage modification may be necessary. Medical consultation is advised. Dosage alterations for Emtri S 250mg/125mg Injection are not suggested for patients exhibiting mild to moderate liver dysfunction.
What if you forget to take Emtri S 250mg/125mg Injection :
Omit a dose of Emtri S 250mg/125mg Injection? Seek medical advice immediately.
Facts to Know About Emtri S 250mg/125mg Injection
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Antimicrobials |
